Nebivolol improves insulin sensitivity in the TGR(Ren2)27 rat

Metabolism: Clinical and Experimental

Volumn 60, Issue 12, 2011, Pages 1757-1766

  Manrique, Camila ^a   Lastra, Guido ^a   Habibi, Javad ^a,b   Pulakat, Lakshmi ^a   Schneider, Rebecca ^a,b   Durante, William ^a   Tilmon, Roger ^a   Rehmer, Jenna ^a   Hayden, Melvin R ^a   Ferrario, Carlos M ^c   Whaley Connell, Adam ^a,b   Sowers, James R ^a,b  

^a University of Missouri   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; GLUCOSE; INSULIN; NEBIVOLOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EX VIVO STUDY; GLUCOSE TRANSPORT; HOMEOSTASIS; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT DURATION;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZOPYRANS; BLOTTING, WESTERN; ETHANOLAMINES; GLUCOSE; HYPOGLYCEMIC AGENTS; IMMUNOPRECIPITATION; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE, SKELETAL; NADPH OXIDASE; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; RANDOM ALLOCATION; RAS PROTEINS; RATS; RATS, INBRED STRAINS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; REACTIVE OXYGEN SPECIES; RENIN; RENIN-ANGIOTENSIN SYSTEM; VASODILATOR AGENTS;

EID: 81155128527     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.04.009     Document Type: Article

References (31)

1. E. Ferrannini, A. Natali, and B. Capaldo Insulin resistance, hyperinsulinemia and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR) Hypertension 30 1997 1144 1149
2. A. Whaley-Connell, and J.R. Sowers Hypertension and insulin resistance Hypertension 54 2009 462 464
3. S.A. Cooper, A. Whaley-Connell, and J. Habibi Role of renin-angiotensin-aldosterone system-induced oxidative stress in cardiovascular insulin resistance Am J Physiol Heart Circ Physiol 293 2007 H2009 H2023
4. C. Manrique, M. Johnson, and J.R. Sowers Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity Hypertension 55 2010 15 17
5. O.T. Raitakari, K.V. Porkka, and T. Rönnemaa The role of insulin in clustering of serum lipids and blood pressure in children and adolescents Diabetologia 38 1995 1042 1050
6. M.C. Blendea, D. Jacobs, and C.S. Stump Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression Am J Physiol Endocrinol Metab 288 2005 E353 E359
7. C. Dessy, J. Saliez, and P. Ghisdal Endothelial beta 3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol Circulation 112 2005 1198 1205 (Pubitemid 41216127)
8. R. Fogari, A. Zoppi, and P. Lazzari Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes J Hum Hypertens 11 1997 753 757 (Pubitemid 27503988)
9. A.M. Garrido, and K.K. Griendling NADPH oxidases and angiotensin II receptor signaling Mol Cell Endocrinol 302 2009 148 158
10. R.P. Robertson, J. Harmon, and P.O. Tran Glucose toxicity in (2)-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection Diabetes 52 2003 581 587 (Pubitemid 36323562)
11. J.C. Frisbee, J.B. Samora, and D.P. Basile Angiostatin does not contribute to skeletal muscle microvascular rarefaction with low nitric oxide bioavailability Microcirculation 14 2007 145 153 (Pubitemid 46951117)
12. J.C. Frisbee, J.B. Samora, and J. Peterson Exercise training blunts microvascular rarefaction in the metabolic syndrome Am J Physiol Heart Circ Physiol 291 2006 H2483 H2492
13. P. Pacher, J.S. Beckman, and L. Liaudet Nitric oxide and peroxynitrite in health and disease Physiol Rev 87 2007 315 424 (Pubitemid 46217686)
14. B.K. Cole, S.R. Keller, and R. Wu Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice Hypertension 55 2010 715 721
15. G. Lastra, J. Habibi, and A.T. Whaley-Connell Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression Endocrinology 150 2009 2561 2568
16. G. Lastra, A. Whaley-Connell, and C. Manrique Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat Am J Physiol Endocrinol Metab 295 2008 E110 E116
17. R.P. Mason, R. Kubant, and R.F. Jacob Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers Am J Hypertens 22 2009 1160 1166
18. T. Celik, A. Iyisoy, and H. Kursaklioglu Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients J Hypertens 24 2006 591 596 (Pubitemid 43261924)
19. L. Poirier, J. Cleroux, and A. Nadeau Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients J Hypertens 19 2001 1429 1435 (Pubitemid 32730460)
20. X. Zhou, L. Ma, and J. Habibi Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat Hypertension 55 2010 880 888
21. A. Whaley-Connell, and J. Habibi Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat Am J Nephrol 30 2009 354 360
22. R. Muniyappa, S. Lee, and H. Chen Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage Am J Physiol Endocrinol Metab 294 2008 E15 E26
23. M. Oelze, A. Daiber, and R.P. Brandes Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats Hypertension 48 2006 677 684 (Pubitemid 44843872)
24. C. Manrique, G. Lastra, and M. Gardner The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress Med Clin North Am 93 2009 569 582
25. T. Pischon, A.M. Sharma, and U. Mansmann Effect of forced titration of nebivolol on response rate in obese hypertensive patients Am J Hypertens 16 2003 98 100 (Pubitemid 36078603)
26. E. Rizos, E. Bairaktari, and A. Kostoula The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study J Cardiovasc Pharmacol Ther 8 2003 127 134 (Pubitemid 36701937)
27. H. Mollnau, E. Schulz, and A. Daiber Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells Arterioscler Thromb Vasc Biol 23 2003 615 621 (Pubitemid 36438074)
28. R.S. Lee-Young, J.E. Ayala, and C.F. Hunley Endothelial nitric oxide synthase is central to skeletal muscle metabolic regulation and enzymatic signaling during exercise in vivo Am J Physiol Regul Integr Comp Physiol 298 2010 R1399 R1408
29. L.A. Lesniewski, A.J. Donato, and B.J. Behnke Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension Am J Physiol Heart Circ Physiol 294 2008 H1840 H1850
30. O.M. Richter, and B. Ludwig Cytochrome c oxidase-structure, function, and physiology of a redox-driven molecular machine Rev Physiol Biochem Pharmacol 147 2003 47 74
31. J.A. Kim, Y. Wei, and J.R. Sowers Role of mitochondrial dysfunction in insulin resistance Circ Res 102 2008 410 414